That extension ran at 18 clinical trial sites in seven countries. In 2023, the drug’s sponsor, Roche, discontinued development of gantenerumab after disappointing study results made it unlikely ...
Parents to hold second 24-hour sleep-out in Dublin over ‘ongoing crisis’ in special education ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback